<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE Specific autoantibodies characterize type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> in childhood but are also found in <z:hpo ids='HP_0003581'>adult-onset</z:hpo> <z:mp ids='MP_0002055'>diabetes</z:mp>, even when initially non-insulin requiring, e.g., with latent autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp> (LADA) </plain></SENT>
<SENT sid="1" pm="."><plain>We aimed to characterize <z:hpo ids='HP_0003581'>adult-onset</z:hpo> autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>RESEARCH DESIGN AND METHODS We consecutively studied 6,156 European diabetic patients attending clinics within 5 years of diagnosis (age range, 30-70 years) examined cross-sectionally clinically and for GAD antibodies (GADA) and antibodies to <z:e sem="disease" ids="C0021670" disease_type="Neoplastic Process" abbrv="">insulinoma</z:e>-associated antigen-2 (IA-2A) and zinc-transporter 8 (ZnT8A) </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS Of 6,156 patients, 541 (8.8%) had GADA and only 57 (0.9%) IA-2A or ZnT8A alone </plain></SENT>
<SENT sid="4" pm="."><plain>More autoantibody-positive than autoantibody-negative patients were younger, leaner, on insulin (49.5 vs. 13.2%), and female (P &lt; 0.0001 for each), though LADA patients (9.7% of total) did not show categorically distinct clinical features from autoantibody-negative type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>Similarly, more GADA patients with high (&gt;200 World Health Organization IU) (n = 403) compared with low (n = 138) titer were female, lean, and insulin treated (54.6 vs. 39.7%) (P &lt; 0.02 for each) </plain></SENT>
<SENT sid="6" pm="."><plain>Autoantibody-positive patients usually had GADA (541 of 598; 90.5%) and had LADA more often than type 1 autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp> (odds ratio 3.3) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS <z:hpo ids='HP_0003581'>Adult-onset</z:hpo> autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp> emerges as a prevalent form of autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>Our results indicate that <z:hpo ids='HP_0003581'>adult-onset</z:hpo> autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp> in Europe encompasses type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> and LADA in the same broad clinical and autoantibody-positive spectrum </plain></SENT>
<SENT sid="9" pm="."><plain>At diagnosis, patients with <z:hpo ids='HP_0003581'>adult-onset</z:hpo> autoimmune <z:mp ids='MP_0002055'>diabetes</z:mp> are usually non-insulin requiring and clinically indistinguishable from patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, though they tend to be younger and leaner </plain></SENT>
<SENT sid="10" pm="."><plain>Only with screening for autoantibodies, especially GADA, can they be identified with certainty </plain></SENT>
</text></document>